DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,196 filers reported holding DANAHER CORPORATION in Q4 2017. The put-call ratio across all filers is 0.78 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $553,480 | -65.7% | 2,196 | -63.8% | 0.01% | -66.7% |
Q4 2022 | $1,611,895 | +2.6% | 6,073 | -0.1% | 0.02% | -4.0% |
Q3 2022 | $1,571,000 | -8.4% | 6,080 | -10.2% | 0.02% | -7.4% |
Q2 2022 | $1,716,000 | +1.8% | 6,769 | +17.8% | 0.03% | +22.7% |
Q1 2022 | $1,686,000 | -0.3% | 5,747 | +11.8% | 0.02% | -15.4% |
Q4 2021 | $1,691,000 | -8.9% | 5,139 | -15.7% | 0.03% | -13.3% |
Q3 2021 | $1,856,000 | +13.5% | 6,096 | +0.0% | 0.03% | +20.0% |
Q2 2021 | $1,635,000 | +35.3% | 6,093 | +13.5% | 0.02% | +25.0% |
Q1 2021 | $1,208,000 | -30.4% | 5,368 | -31.3% | 0.02% | -41.2% |
Q4 2020 | $1,736,000 | -0.6% | 7,814 | -3.7% | 0.03% | -2.9% |
Q3 2020 | $1,747,000 | +17.6% | 8,114 | -3.4% | 0.04% | +45.8% |
Q2 2020 | $1,485,000 | -35.7% | 8,396 | -49.7% | 0.02% | +14.3% |
Q1 2020 | $2,310,000 | +59.2% | 16,684 | +76.5% | 0.02% | +133.3% |
Q4 2019 | $1,451,000 | +2.9% | 9,453 | -3.2% | 0.01% | 0.0% |
Q3 2019 | $1,410,000 | +687.7% | 9,761 | +677.8% | 0.01% | +800.0% |
Q2 2019 | $179,000 | +2457.1% | 1,255 | +2224.1% | 0.00% | – |
Q1 2019 | $7,000 | +16.7% | 54 | 0.0% | 0.00% | – |
Q4 2018 | $6,000 | 0.0% | 54 | 0.0% | 0.00% | – |
Q3 2018 | $6,000 | +20.0% | 54 | 0.0% | 0.00% | – |
Q2 2018 | $5,000 | 0.0% | 54 | 0.0% | 0.00% | – |
Q1 2018 | $5,000 | 0.0% | 54 | 0.0% | 0.00% | – |
Q4 2017 | $5,000 | 0.0% | 54 | 0.0% | 0.00% | – |
Q3 2017 | $5,000 | 0.0% | 54 | 0.0% | 0.00% | – |
Q2 2017 | $5,000 | 0.0% | 54 | 0.0% | 0.00% | – |
Q1 2017 | $5,000 | -16.7% | 54 | -34.1% | 0.00% | – |
Q4 2016 | $6,000 | 0.0% | 82 | 0.0% | 0.00% | – |
Q3 2016 | $6,000 | 0.0% | 82 | +32.3% | 0.00% | – |
Q2 2016 | $6,000 | 0.0% | 62 | 0.0% | 0.00% | – |
Q1 2016 | $6,000 | 0.0% | 62 | 0.0% | 0.00% | – |
Q4 2015 | $6,000 | +50.0% | 62 | +40.9% | 0.00% | – |
Q3 2015 | $4,000 | 0.0% | 44 | 0.0% | 0.00% | – |
Q2 2015 | $4,000 | – | 44 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |